Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings by Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Masaaki Hidaka, Susumu Eguchi, Satoshi Matsuo, Kazuaki Tajima, Toshihisa Matsuzaki, Satsuki Hashimoto, Kazuo Ooba, Yuki Kugiyama, Hiroshi Yatsuhashi, Yasuhide Motoyoshi, Masaya Shigeno, Noboru Kinoshita, Kazuhiko Nakao

Get full text